Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation
Molecular Therapy · 2026-08 · 34 (8) · 4903-4920
DOI: 10.1016/j.ymthe.2026.04.062 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Therapy, 2026-08. Verfasst von Feng Liao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, Department of Nephrology, Guangdong Provincial People's Hospital (…. Hauptthemen laut MEDLINE: Receptor, Transforming Growth Factor-beta Type II, Pulmonary Fibrosis, Kidney Diseases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Guangzhou Municipal Science and Technology Bureau, Department of Science and Technology of Guangdong Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guangdong-Hong Kong Joint Laboratory on Immunological and Genetic Kidney Diseases, Department of Nephrology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, G…
- Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China.
- State Key Laboratory of Traditional Chinese Medicine Syndrome, Guangzhou University of Chinese Medicine, Guangzhou 510006, China; Chinese Medicine Guangdong Laboratory, Hengqin, Guangdong 519031, China.
- Department of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510000, China.
- School of Pharmaceutical Sciences, Guangzhou University of Chinese Medicine, Guangzhou 510006, China.
- Department of Nephrology, The Third Affiliated Hospital of Southern Medical University, Guangzhou 510000, China. Electronic address: chenjunzhe0304@163.com.
Förderung
- Guangzhou Municipal Science and Technology Bureau
- Department of Science and Technology of Guangdong Province
- National Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province
Zitieren
APA
Liao, F., Liu, P., Wu, L., Zhong, T., Li, J., Chen, J., Wu, C., Liu, Y., Chen, J., Li, G., & Wang, W. (2026). Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation. Molecular Therapy, 34(8), 4903-4920. https://doi.org/10.1016/j.ymthe.2026.04.062
Vancouver
Liao F, Liu P, Wu L, Zhong T, Li J, Chen J, et al. Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation. Molecular Therapy. 2026;34(8):4903-4920. doi:10.1016/j.ymthe.2026.04.062
BibTeX
@article{Liao2026,
author = {Liao, Feng and Liu, Peng and Wu, Liumei and Zhong, Tingjing and Li, Jiaxiao and Chen, Jiafan and Wu, Chen and Liu, Ya and Chen, Junzhe and Li, Geng and Wang, Wenbiao},
title = {Herbacetin as a novel therapeutic agent for pulmonary and renal fibrosis by targeting TGFBR2 for degradation},
journal = {Molecular Therapy},
year = {2026},
volume = {34},
number = {8},
pages = {4903--4920},
doi = {10.1016/j.ymthe.2026.04.062}
}
EUVIMED